{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Auger electrons", "Chelator", "Molecular radionuclide therapy", "Oxidation", "Thallium-201"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33906122", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "04", "Day": "17"}], "ELocationID": ["10.1016/j.nucmedbio.2021.03.012", "S0969-8051(21)00055-X"], "Journal": {"ISSN": "1872-9614", "JournalIssue": {"Volume": "98-99", "PubDate": {"Year": "2021", "Season": "Jul-Aug"}}, "Title": "Nuclear medicine and biology", "ISOAbbreviation": "Nucl Med Biol"}, "ArticleTitle": "Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals.", "Pagination": {"StartPage": "1", "EndPage": "7", "MedlinePgn": "1-7"}, "Abstract": {"AbstractText": ["Thallium-201 is a radionuclide that has previously been used clinically for myocardial perfusion scintigraphy. Although in this role it has now been largely replaced by technetium-99 m radiopharmaceuticals, thallium-201 remains attractive in the context of molecular radionuclide therapy for cancer micrometastases or single circulating tumour cells. This is due to its Auger electron (AE) emissions, which are amongst the highest in total energy and number per decay for AE-emitters. Currently, chemical platforms to achieve this potential through developing thallium-201-labelled targeted radiopharmaceuticals are not available. Here, we describe convenient methods to oxidise [<sup>201</sup>Tl]Tl(I) to chelatable [<sup>201</sup>Tl]Tl(III) and identify challenges in stable chelation of thallium to support future synthesis of effective [<sup>201</sup>Tl]-labelled radiopharmaceuticals.", "A plasmid pBR322 assay was carried out to determine the DNA damaging properties of [<sup>201</sup>Tl]Tl(III). A range of oxidising agents (ozone, oxygen, hydrogen peroxide, chloramine-T, iodogen, iodobeads, trichloroisocyanuric acid) and conditions (acidity, temperature) were assessed using thin layer chromatography. Chelators EDTA, DTPA and DOTA were investigated for their [<sup>201</sup>Tl]Tl(III) radiolabelling efficacy and complex stability.", "Isolated plasmid studies demonstrated that [<sup>201</sup>Tl]Tl(III) can induce single and double-stranded DNA breaks. Iodo-beads, iodogen and trichloroisocyanuric acid enabled more than 95% conversion from [<sup>201</sup>Tl]Tl(I) to [<sup>201</sup>Tl]Tl(III) under conditions compatible with future biomolecule radiolabelling (mild pH, room temperature and post-oxidation removal of oxidising agent). Although chelation of [<sup>201</sup>Tl]Tl(III) was possible with EDTA, DTPA and DOTA, only radiolabeled DOTA showed good stability in serum.", "Decay of [<sup>201</sup>Tl]Tl(III) in proximity to DNA causes DNA damage. Iodobeads provide a simple, mild method to convert thallium-201 from a 1+ to 3+ oxidation state and [<sup>201</sup>Tl]Tl(III) can be chelated by DOTA with moderate stability. Of the well-established chelators evaluated, DOTA is most promising for future molecular radionuclide therapy using thallium-201; nevertheless, a new generation of chelating agents offering resistance to reduction and dissociation of [<sup>201</sup>Tl]Tl(III) complexes is required."], "CopyrightInformation": "Copyright \u00a9 2021 The Author(s). Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King's College London, School of Biomedical Engineering and Imaging Sciences, 4th Floor Lambeth Wing, St Thomas' Hospital, London SE1 7EH, United Kingdom."}], "LastName": "Rigby", "ForeName": "Alex", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King's College London, School of Biomedical Engineering and Imaging Sciences, 4th Floor Lambeth Wing, St Thomas' Hospital, London SE1 7EH, United Kingdom."}], "LastName": "Blower", "ForeName": "Julia E", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King's College London, School of Biomedical Engineering and Imaging Sciences, 4th Floor Lambeth Wing, St Thomas' Hospital, London SE1 7EH, United Kingdom."}], "LastName": "Blower", "ForeName": "Philip J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King's College London, School of Biomedical Engineering and Imaging Sciences, 4th Floor Lambeth Wing, St Thomas' Hospital, London SE1 7EH, United Kingdom. Electronic address: samantha.terry@kcl.ac.uk."}], "LastName": "Terry", "ForeName": "Samantha Y A", "Initials": "SYA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King's College London, School of Population Health and Environmental Sciences, Analytical, Environmental and Forensic Sciences, Franklin-Wilkins Building, Stamford Street, London SE1 9NH, United Kingdom. Electronic address: Vincenzo.abbate@kcl.ac.uk."}], "LastName": "Abbate", "ForeName": "Vincenzo", "Initials": "V"}], "GrantList": [{"Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "203148", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "MC_PC_17164", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Nucl Med Biol", "NlmUniqueID": "9304420", "ISSNLinking": "0969-8051"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Radiopharmaceuticals"}, {"RegistryNumber": "0", "NameOfSubstance": "Thallium Radioisotopes"}, {"RegistryNumber": "H91Z8HBK1B", "NameOfSubstance": "Thallium-201"}, {"RegistryNumber": "0", "NameOfSubstance": "Chelating Agents"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Radiopharmaceuticals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Thallium Radioisotopes"}, {"QualifierName": ["methods"], "DescriptorName": "Radiochemistry"}, {"QualifierName": [], "DescriptorName": "Electrons"}, {"QualifierName": ["chemistry"], "DescriptorName": "Chelating Agents"}, {"QualifierName": [], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Buchegger F, Perillo-Adamer F, Dupertuis YM, Bischof Delaloye A. Auger radiation targeted into DNA: a therapy perspective. Eur J Nucl Med Mol Imaging. 2006;33:1352\u201363. doi: 10.1007/s00259-006-0187-2.", "ArticleIdList": ["10.1007/s00259-006-0187-2", "16896663"]}, {"Citation": "Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med. 2005;46:4\u201313.", "ArticleIdList": ["15653646"]}, {"Citation": "Pouget J, Santoro L, Raymond L, Chouin N, Bardi\u00e8s M, Bascoul-Mollevi C, et al. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res. 2008;170:192\u2013200. doi: 10.1667/RR1359.1.", "ArticleIdList": ["10.1667/RR1359.1", "18666820"]}, {"Citation": "Paillas S, Ladjohounlou R, Lozza C, Pichard A, Boudousq V, Jarlier M, et al. Localized irradiation of cell membrane by Auger electrons is cytotoxic through oxidative stress-mediated nontargeted effects. Antioxid Redox Signal. 2016;25:467\u201384. doi: 10.1089/ars.2015.6309.", "ArticleIdList": ["10.1089/ars.2015.6309", "PMC5028911", "27224059"]}, {"Citation": "Terry SYA, Vallis KA. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:1298\u2013305. doi: 10.1016/j.ijrobp.2011.09.051.", "ArticleIdList": ["10.1016/j.ijrobp.2011.09.051", "PMC6175060", "22336201"]}, {"Citation": "Aghevlian S, Lu Y, Winnik MA, Hedley DW, Reilly RM. Panitumumab modified with metal-chelating polymers (MCP) complexed to 111 in and 177 Lu - an EGFR-targeted theranostic for pancreatic cancer. Mol Pharm. 2018;15:1150\u20139. doi: 10.1021/acs.molpharmaceut.7b01000.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b01000", "29314858"]}, {"Citation": "Costantini DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM. Antitumor effects and normal-tissue toxicity of1nIn-nuclear localization sequence-trastuzumab in Athymic mice bearing HER-positive human breast cancer xenografts. J Nucl Med. 2010;51:1084\u201391. doi: 10.2967/jnumed.109.072389.", "ArticleIdList": ["10.2967/jnumed.109.072389", "20554744"]}, {"Citation": "Caplin ME, Mielcarek W, Buscombe JR, Jones AL, Croasdale PL, Cooper MS, et al. Toxicity of high-activity 111In-octreotide therapy in patients with disseminated neuroendocrine tumours. Nucl Med Commun. 2000;21:97\u2013102. doi: 10.1097/00006231-200001000-00016.", "ArticleIdList": ["10.1097/00006231-200001000-00016", "10717909"]}, {"Citation": "Kassis AI, Fayad F, Kinsey BM, Sastry KS, Taube RAAS. Radiotoxicity of 125I in mammalian cells. Radiat Res. 1987;111:305\u201318.", "ArticleIdList": ["3628718"]}, {"Citation": "Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, et al. 111 In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med. 2000;41:429\u201338.", "ArticleIdList": ["10716315"]}, {"Citation": "Song L, Falzone N, Vallis KA. EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy ofEGFR-positive cancer. Int J Radiat Biol. 2016;92:716\u201323. doi: 10.3109/09553002.2016.1145360.", "ArticleIdList": ["10.3109/09553002.2016.1145360", "PMC5116916", "26999580"]}, {"Citation": "Reilly RM, Chen P, Wang J, Scollard D, Cameron R, Vallis KA. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. J Nucl Med. 2006;47:1023\u201331.", "ArticleIdList": ["16741313"]}, {"Citation": "Slastnikova TA, Koumarianou E, Rosenkranz AA, Vaidyanathan G, Lupanova TN, Sobolev AS, et al. Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting 125I. EJNMMI Res. 2012;2:1\u201310. doi: 10.1186/2191-219X-2-59.", "ArticleIdList": ["10.1186/2191-219X-2-59", "PMC3511205", "23107475"]}, {"Citation": "Violet JA, Farrugia G, Skene C, White J, Lobachevsky P, Martin R. Triple targeting of Auger emitters using octreotate conjugated to a DNA-binding ligand and a nuclear localizing signal. Int J Radiat Biol. 2016;92:707\u201315. doi: 10.3109/09553002.2016.1157278.", "ArticleIdList": ["10.3109/09553002.2016.1157278", "27010622"]}, {"Citation": "Pirovano G, Jannetti SA, Carter LM, Sadique A, Kossatz S, Guru N, et al. Targeted brain tumor radiotherapy using an auger emitter. Clin Cancer Res. 2020;26:2871\u201381. doi: 10.1158/1078-0432.CCR-19-2440.", "ArticleIdList": ["10.1158/1078-0432.CCR-19-2440", "PMC7299758", "32066626"]}, {"Citation": "Juri\u0107 I, Fazlibegovi\u0107 E, Pravdi\u0107 D, Star\u010devi\u0107 B, Punda A, Hui\u0107 D, et al. The significance of Thallium-201-chloride SPECT myocardial perfusion imaging in the management of patients with stable chronic coronary artery disease. Clin Med Insights Cardiol. 2018;12 doi: 10.1177/1179546818790562.", "ArticleIdList": ["10.1177/1179546818790562", "PMC6056776", "30046258"]}, {"Citation": "Yildirim M, Ikbal M, Tos T, Seven B, Pirim I, Varoglu E. Genotoxicity of Thallium-201 in patients with angina pectoris undergoing myocardial perfusion study. Tohoku J Exp Med. 2005;206:299\u2013304. doi: 10.1620/tjem.206.299.", "ArticleIdList": ["10.1620/tjem.206.299", "15997200"]}, {"Citation": "Gupta SM, Herrera N, Spencer RP, Hosain F, Crucitti TW. Testicular-scrotal content of 201T1 and 67Ga after intravenous administration. IntJ Nucl Med Biol. 1981;8:211\u20132. doi: 10.1016/0047-0740(81)90079-6.", "ArticleIdList": ["10.1016/0047-0740(81)90079-6", "7319717"]}, {"Citation": "Rao DV, Govelitz GF, Sastry KSR. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med. 1983;24:145\u201353.", "ArticleIdList": ["6822877"]}, {"Citation": "bin Othman MF, Mitry NR, Lewington VJ, Blower PJ, Terry SYA. Re-assessing gallium-67 as a therapeutic radionuclide. Nucl Med Biol. 2017;46:12\u20138. doi: 10.1016/j.nucmedbio.2016.10.008.", "ArticleIdList": ["10.1016/j.nucmedbio.2016.10.008", "PMC5303015", "27915165"]}, {"Citation": "bin Othman MF, Verger E, Costa I, Tanapirakgul M, Cooper MS, Imberti C, et al. In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab. Nucl Med Biol. 2020;80\u201381:57\u201364. doi: 10.1016/j.nucmedbio.2019.12.004.", "ArticleIdList": ["10.1016/j.nucmedbio.2019.12.004", "PMC7099941", "31889612"]}, {"Citation": "Kassis AI, Adelstein SJ, Haydock C, Sastry KSR. Thallium-201: an experimental and a theoretical radiobiological approach to dosimetry. J Nucl Med. 1983;24:1164\u201375.", "ArticleIdList": ["6644377"]}, {"Citation": "Howell RW. Radiation spectra for Auger-electron emitting radionuclides: report no. 2 of AAPM nuclear medicine task group no. 6. Med Phys. 1992;19:1371\u201383.", "ArticleIdList": ["1461199"]}, {"Citation": "Salim R, Taherparvar P. Monte Carlo single-cell dosimetry using Geant4-DNA: the effects of cell nucleus displacement and rotation on cellular S values. Radiat Environ Biophys. 2019;58:353\u201371. doi: 10.1007/s00411-019-00788-z.", "ArticleIdList": ["10.1007/s00411-019-00788-z", "30927051"]}, {"Citation": "Falzone N, Lee BQ, Fernandez-Varea JM, Kartsonaki C, Stuchbery AE, Kibedi T, et al. Absorbed dose evaluation of Auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values. Phys Med Biol. 2017;62:2239\u201353.", "ArticleIdList": ["28102829"]}, {"Citation": "Falzone N, Fern\u00e1ndez-Varea JM, Flux G, Vallis KA. Monte Carlo evaluation of auger electron-emitting theranostic radionuclides. J Nucl Med. 2015;56:1441\u20136. doi: 10.2967/jnumed.114.153502.", "ArticleIdList": ["10.2967/jnumed.114.153502", "26205298"]}, {"Citation": "Mahdi SM, Babak SB. Dosimetry study on Auger electron-emitting nuclear medicine radioisotopes in micrometer and nanometer scales using Geant4-DNA simulation. Int J Radiat Biol. 2020;96:1452\u201365. doi: 10.1080/09553002.2020.1820608.", "ArticleIdList": ["10.1080/09553002.2020.1820608", "32910718"]}, {"Citation": "Jalilian AR, Hosseini MA, Majdabadi A, Saddadi F. Evaluation of [201Tl](III) Vancomycin in normal rats. Nucl Med Rev Cent East Eur. 2008;11:1\u20134.", "ArticleIdList": ["19173180"]}, {"Citation": "Jalilian AR, Akhlaghi M, Shirazi B, Aboudzadeh R, Raisali G, Salouti M, et al. [201Tl] (III)-bleomyein for tumor imaging. Radiochim Acta. 2006;94:453\u20139. doi: 10.1524/ract.2006.94.8.453.", "ArticleIdList": ["10.1524/ract.2006.94.8.453"]}, {"Citation": "Jalilian AR, Hosseini MA, Karimian A, Saddadi F, Sadeghi M. Preparation and biodistribution of [201Tl](III)vancomycin complex in normal rats. Nukleonika. 2006;51:203\u20138."}, {"Citation": "Jalilian AR, Khorrami A, Tavakoli MB, Kamali-Dehghan M, Kamrani YY. Development of [201Tl](III)-DTPA-human polyclonal antibody complex for inflammation detection. Radiochim Acta. 2007;95:669\u201375. doi: 10.1524/ract.2007.95.11.669.", "ArticleIdList": ["10.1524/ract.2007.95.11.669"]}, {"Citation": "Hijnen NM, de Vries A, Blange R, Burdinski D, Grull H. Synthesis and in vivo evaluation of 201Tl(III)-DOTA complexes for applications in SPECT imaging. Nucl Med Biol. 2011;38:585\u201392. doi: 10.1016/j.nucmedbio.2010.10.009.", "ArticleIdList": ["10.1016/j.nucmedbio.2010.10.009", "21531296"]}, {"Citation": "Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. doi: 10.1038/nmeth.2089.", "ArticleIdList": ["10.1038/nmeth.2089", "PMC5554542", "22930834"]}, {"Citation": "Bocci V. Efficient Labelling of tissue-soluble proteins with iodine-ill using chloramine T. Nature. 1964;203:985\u20136. doi: 10.1038/203986a0.", "ArticleIdList": ["10.1038/203986a0", "14203524"]}, {"Citation": "Balagurumoorthy P, Chen K, Bash RC, Adelstein SJ, Kassis AI. Mechanisms underlying production of double-strand breaks in plasmid DNA after decay of 125I-Hoechst. Radiat Res. 2006;166:333\u201344. doi: 10.1667/RR3591.1.", "ArticleIdList": ["10.1667/RR3591.1", "16881734"]}, {"Citation": "Kassis AI, Harapanhalli RS, Adelstein SJ. Comparison of strand breaks in plasmid DNA after positional changes of auger electron-emitting iodine-125. Radiat Res. 1999;151:167\u201376. doi: 10.2307/3579767.", "ArticleIdList": ["10.2307/3579767", "9952301"]}, {"Citation": "Kassis AI, Harapanhalli RS, Adelstein SJ. Strand breaks in plasmid DNA after positional changes of auger electron-emitting iodine-125: direct compared to indirect effects. Radiat Res. 1999;152:530\u20138. doi: 10.2307/3580150.", "ArticleIdList": ["10.2307/3580150", "10521930"]}, {"Citation": "Sahu SK, Kortylewicz ZP, Baranowska-Kortylewicz J, Taube RA, Adelstein SJ, Kassis AI. Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA. Radiat Res. 1997;147:401\u20138. doi: 10.2307/3579495.", "ArticleIdList": ["10.2307/3579495", "9092918"]}, {"Citation": "Kassis AI, Adelstein SJ. 5-[125I]iodo-2\u2019-deoxyuridine in the radiotherapy of solid CNS tumors in rats. Acta Oncol (Madr) 1996;35:935\u20139. doi: 10.3109/02841869609104048.", "ArticleIdList": ["10.3109/02841869609104048", "9004774"]}, {"Citation": "Kassis AI, Kirichian AM, Wang K, Semnani ES, Adelstein SJ. Therapeutic potential of 5-[125I]iodo-2\u2019-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. Int J Radiat Biol. 2004;80:941\u20136. doi: 10.1080/09553000400017671.", "ArticleIdList": ["10.1080/09553000400017671", "15764406"]}, {"Citation": "Balagurumoorthy P, Wang K, Adelstein SJ, Kassis AI. DNA double-strand breaks induced by decay of 123I-labeled Hoechst 33342: role of DNA topology. Int J Radiat Biol. 2008;84:976\u201383. doi: 10.1080/09553000802512568.", "ArticleIdList": ["10.1080/09553000802512568", "PMC2829301", "19061121"]}, {"Citation": "Lobachevsky PN, Martin RF. Plasmid DNA breakage by decay of DNA-associated auger emitters: experiments with 123I/125I-iodoHoechst 33258. Int J Radiat Biol. 2004;80:915\u201320. doi: 10.1080/09553000400017754.", "ArticleIdList": ["10.1080/09553000400017754", "15764402"]}, {"Citation": "Reissig F, Wunderlich G, Runge R, Freudenberg R, L\u00fchr A, Kotzerke J. The effect of hypoxia on the induction of strand breaks in plasmid DNA by alpha-, beta- and Auger electron-emitters 223Ra, 188Re, 99mTc and DNA-binding 99mTc-labeled pyrene. Nucl Med Biol. 2020;80-81:65\u201370. doi: 10.1016/j.nucmedbio.2020.01.003.", "ArticleIdList": ["10.1016/j.nucmedbio.2020.01.003", "32001104"]}, {"Citation": "Adelstein SJ, Kassis AI. Strand breaks in plasmid DNA following positional changes of auger-electron-emitting radionuclides. Acta Oncol (Madr) 1996;35:797\u2013801. doi: 10.3109/02841869609104029.", "ArticleIdList": ["10.3109/02841869609104029", "9004755"]}, {"Citation": "Jalilian A, Atomic I, Agency E, Sciences M, Sciences M. Preparation and evaluation of [201Tl](III) - DTPA-HIgG for inflammation detection preparation and evaluation of [T1](III) -DTPA-HIgG for inflammation detection. Iran J Radiat Res. 2006;4:105\u201314."}, {"Citation": "Jalilian AR, Yari-Kamrani Y, Kamali-Dehghan M, Rajabifar S. Preparation and evaluation of [201H](III)-DTPA complex for cell labeling. J Radioanal Nucl Chem. 2008;275:109\u201314. doi: 10.1007/s10967-007-6938-0.", "ArticleIdList": ["10.1007/s10967-007-6938-0"]}, {"Citation": "Koppenol WH. The reduction potential of the couple O3/O3. FEBS Lett. 1982;140:169\u201372. doi: 10.1016/0014-5793(82)80886-7.", "ArticleIdList": ["10.1016/0014-5793(82)80886-7", "7084460"]}, {"Citation": "Greenwood FC, Hunter WM, Glover JS. The preparation of I-131-Labelled human growth hormone of high specific. Biochem J. 1963;89:114\u201323. doi: 10.1042/bj0890114.", "ArticleIdList": ["10.1042/bj0890114", "PMC1202279", "14097352"]}, {"Citation": "Blower PJ, Puncher MRB, Kettle AG, George S, Dorsch S, Leak A, et al. Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humans. Eur J Nucl Med. 1998;25:101\u20138. doi: 10.1007/s002590050200.", "ArticleIdList": ["10.1007/s002590050200", "9473255"]}, {"Citation": "Vasudeva Murphy AR, Sanjiva Rao FASc B. Oxidation by chloramine-T. Proc Indiana Acad Sci. 1951;35:459\u201364."}, {"Citation": "Tilstam U, Weinmann H. Trichloroisocyanuric acid: a safe and efficient oxidant. Org Process Res Dev. 2002;6:384\u201393. doi: 10.1021/op010103h.", "ArticleIdList": ["10.1021/op010103h"]}, {"Citation": "Fodor T, B\u00e1nyai I, B\u00e9nyei A, Platas-Iglesias C, Purgel M, Horv\u00e1th G, et al. [TIIII(dota)] : an extraordinarily robust macrocyclic complex. Inorg Chem. 2015;54:5426\u201337. doi: 10.1021/acs.inorgchem.5b00458.", "ArticleIdList": ["10.1021/acs.inorgchem.5b00458", "25977977"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "11"}, {"Year": "2021", "Month": "3", "Day": "25"}, {"Year": "2021", "Month": "3", "Day": "30"}, {"Year": "2021", "Month": "4", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "27", "Hour": "20", "Minute": "24"}, {"Year": "2021", "Month": "5", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33906122", "EMS124475", "PMC7610824", "10.1016/j.nucmedbio.2021.03.012", "S0969-8051(21)00055-X"]}}], "PubmedBookArticle": []}